Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $112.80 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dynavax Technologies Corporation | $39.65 | 2 | $0 (2018) |
| Novo Nordisk Inc | $19.48 | 1 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $15.67 | 1 | $0 (2019) |
| Cranial Technologies, Inc | $13.69 | 1 | $0 (2020) |
| Lilly USA, LLC | $13.15 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $11.16 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.48 | 1 | Novo Nordisk Inc ($19.48) |
| 2020 | $13.69 | 1 | Cranial Technologies, Inc ($13.69) |
| 2019 | $26.83 | 2 | JAZZ PHARMACEUTICALS INC. ($15.67) |
| 2018 | $52.80 | 3 | Dynavax Technologies Corporation ($39.65) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 01/23/2020 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $13.69 | General |
| Category: Cranial Orthotic | ||||||
| 11/19/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PAIN | ||||||
| 09/24/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Immunology | ||||||
| 12/15/2018 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/06/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 10/17/2018 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Hepatitis B Vaccine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 424 | 522 | $85,567 | $37,794 |
| 2022 | 9 | 426 | 507 | $68,627 | $31,789 |
| 2021 | 11 | 416 | 461 | $47,789 | $24,312 |
| 2020 | 9 | 318 | 382 | $42,397 | $16,905 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 179 | $27,590 | $10,974 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $13,926 | $8,561 | 61.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 95 | $21,900 | $8,539 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,106 | $2,580 | 36.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $4,634 | $2,290 | 49.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $1,940 | $1,435 | 74.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,425 | $1,315 | 29.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 25 | 26 | $2,626 | $1,091 | 41.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $851.00 | $718.75 | 84.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 23 | $272.00 | $193.20 | 71.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 20 | $180.00 | $68.20 | 37.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $117.00 | $28.60 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 203 | $28,675 | $12,129 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $13,504 | $8,498 | 62.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 77 | $15,779 | $6,416 | 40.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $5,226 | $2,053 | 39.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,615 | $1,165 | 72.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 22 | 23 | $2,323 | $700.77 | 30.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $777.00 | $627.27 | 80.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 38 | 44 | $440.00 | $127.74 | 29.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 30 | 32 | $288.00 | $71.29 | 24.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 132 | $18,288 | $8,936 | 48.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $7,602 | $4,770 | 62.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 54 | $11,007 | $4,614 | 41.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $4,189 | $1,799 | 42.9% |
About Dr. Daniel Meram, M.D
Dr. Daniel Meram, M.D is a Family Medicine healthcare provider based in Bloomfield Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1215354493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Meram, M.D has received a total of $112.80 in payments from pharmaceutical and medical device companies, with $19.48 received in 2024. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($112.80).
As a Medicare-enrolled provider, Meram has provided services to 1,584 Medicare beneficiaries, totaling 1,872 services with total Medicare billing of $110,800. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bloomfield Township, MI
- Active Since 03/25/2014
- Last Updated 11/05/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215354493
Products in Payments
- Heplisav-B (Drug) $39.65
- Rybelsus (Drug) $19.48
- SUNOSI (Drug) $15.67
- Doc Band (Device) $13.69
- TRULICITY (Drug) $13.15
- SIMPONI (Biological) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.